Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FASENRA Regulatory Postmarketing Surveillance in Korea

NCT05091333 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT05091333
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05091333 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FASENRA Regulatory Postmarketing Surveillance in Korea
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
March 11, 2022
Completion date
March 6, 2025
Enrollment
51 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, egpa(eosinophilic granulomatosis with polyangiitis)